Meetings and Courses

Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided as a service to readers；inclusion does not imply endorsement by the Hepatobiliary & Pancreatic Diseases International.

Section editor

Shui-Ying Lei

Email: hbpdint@126.com

November， 2016

New horizons in cancer research： delivering cures through cancer science

November 2-5， 2016； Shanghai Marriott Parkview Hotel， Shanghai， China

The conference will serve as a dynamic platform for the advancement of cancer science and medicine， and for the establishment of new collaborations on an international scale. The highly engaging and interactive fourday multidisciplinary program will cover the entire cancer research spectrum - from basic， to translational， to clinical - drawing on the latest findings presented at the 107th Annual Meeting of the AACR to be held in New Orleans， April 16-20， 2016. The conference will begin with two keynote lectures during the opening plenary session， followed by a strong scientific program composed of seven plenary sessions on topics covering the entire cancer research spectrum， including： prevention and early detection， genomics and epigenomics， tumor heterogeneity， tumor metabolism， developmental pathways， immunotherapy， targeted therapy， and precision medicine. For more information， please visit： http：// www.aacr.asia/.

BIR annual congress

November 3-4， 2016； London， UK

Divided into two parallel sessions over 2 days， the BIR annual congress provides an open and relaxed environment for delegates to share and exchange ideas and experiences， visit industry exhibition， showcase their research via the interactive ePoster sessions， and network both during the day and at the evening networking events. Participants can be anyone with an interest and passion for radiology， radiation oncology and the underlying sciences， including radiologists， physicists， radiographers， oncologists， physicians and radiation protection advisers， and supervisors. For more information， please visit： https：//birorgukportal.force.com/cpbase__event_ detail？id=a1720000009SyUlAAK&site=a0N2000000CO vFsEAL.

Minimally invasive and robotic abdominal wall surgery course

November 3-4， 2016； Celebration， FL， USA

The course is organized by Florida Hospital Nicholson Center & Florida Hospital Celebration Health. The course learning objectives are to： 1） Examine and analyze the minimally invasive surgery （MIS） techniques and methodology behind abdominal wall hernia repairs；2） Discuss the role of robotic surgical system in correcting abdominal wall defects； and 3） Use component separation techniques and their indications on complex abdominal wall cases. Florida Hospital designates this live activity for a maximum of 17.45 AMA PRA Category 1 Credits?. Each physician should only claim those hours of credit commensurate with the extent of their participation in the activity. Registration Price is $2，000. For more information， please visit： https：//www.nicholsoncenter.com/news-events/events/2016-minimallyinvasive-and-robotic-abdominal-surgery-course.

Primary care general update

November 10-11， 2016； London， UK

The primary care general update will provide 12 core clinical topics and 12 CPD credits. Across the two-day course， each clinical session incorporates real-life case studies， interactive polls and practical demos to bring the latest evidence， new developments and guidelines in general practice. Key features of the course： 1） Expert speakers will give practical tips on how to interpret latest guidelines and evidence in the practice； 2） Interactive voting - make decisions on cases as attendees would in the practice and see if attendees' peers and the speakers agree； 3） Dedicated question time with the experts -quiz them on a tricky condition， or get advice on how to manage a specific patient； 4） The opportunity to discuss key topics with others working across the primary care teams in a range of roles. For more information， please visit： http：//masterclasses.bmj.com/gp-general-updatelondon-november-2016.

Improving cancer risk prediction for prevention and early detection

November 16-19， 2016； Rosen Plaza Hotel， Orlando，F(xiàn)lorida， USA

Conference co-chairpersons are Graham A. Colditz from Washington University， Saint Louis， Missouri；Susan M. Gapstur from American Cancer Society， Atlanta， Georgia； Kenneth R. Muir from University of Manchester， Manchester， United Kingdom； and Mark E. Sherman from National Cancer Institute， Bethesda，Maryland. This conference will convene internationally recognized translational and population scientists from the fields of genomics， statistics， epidemiology， bioinformatics， and behavior to present the latest advances in the development， validation， and implementation of cancer risk prediction models. Plenary sessions will address cross-cutting principles and considerations with broad application， as well as cover approaches to predict the environmental and genetic risks of specific types of tumors. For more information， please visit：http：//www.aacr.org/Meetings/Pages/MeetingDetail. aspx？EventItemID=102#.V9-eUewQgfk.

Update CME - internal medicine and primary care

November 17-20， 2016； Chicago， USA

The 4-day primary care will provide： 1） Comprehensive internal medicine & primary care program covers diverse range of topics； 2） concise 45-minute practice update presentations with extended Q&A's； 3） presentations provided to all participants in electronic format； 4）excellent speakers from Northwestern University， Rush University Medical Center and the University of Chicago. For more information， please visit： http：//amf-cme. org/en_US/course/7/update-cme-internal-medicineand-primary-care.

Fifth cross-strait forum and world gastroenterology digestive forum

November 18-20， 2016； Xiamen， China

The gastroenterology， digestive endoscopy and hepatology experts from the mainland， Taiwan， Hong Kong and Macao of China together with those experts from abroad will attend this cross-strait forum. This forum aims to exchange the current situation of innovation work and form a consensus for the early detection and treatment of gastrointestinal cancer， gastrointestinal microflora， gastrointestinal mucosal lesions， digestive new technology， various types of liver diseases， biliary and pancreatic diseases and digestive endoscopy. For more information， please contact： Quan-Yi Gao， Tel/Fax：+86-592-2993032； Email： XMdigest@163.com.

EORTC-NCI-AACR molecular targets and cancer therapeutics symposium

November 29 - December 2， 2016； ICM - International Congress Center Munich， Munich， Germany

Hosted by the European Organization for Research and Treatment of Cancer （EORTC）， the National Cancer Institute （NCI） and the American Association for Cancer Research （AACR）， the 28th EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics will take place in Munich， Germany from November 29 to December 2， 2016. The 2016 symposium will bring together around 2000 academics， scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development，target selection and the impact of new discoveries in molecular biology. For more information， please contact： Secretariat， ECCO-the European CanCer Organisation， Avenue E. Mounier， 83 B-1200 Brussels - Belgium；Tel.： +32-0-2775-0201； Fax： +32-0-2775-0200； Email：ena2016@ecco-org.euwebsite： https：//www.ecco-org.eu/ ENA.

December

8th European multidisciplinary colorectal cancer congress

December 11-13， 2016； Amsterdam， Netherlands

The European multidisciplinary colorectal cancer congress （EMCCC） provides a platform for in-depth multidisciplinary interaction among the various research areas. The conference will have separate workshops on surgery， medical oncology， radiotherapy， pathology， imaging， gastroenterology， and genetics， but all other sessions are plenary in order to have optimal interaction between all disciplines. The format of the conference consists of workshops， keynote lecture， controversy sessions， satellite symposia， and oral and poster presentations on prevention and screening， diagnosis and follow-up， translational research， multidisciplinary management， genetics， evaluation of treatment， and updates on randomized CRC trials. For more information，please visit： http：//www.emccc2016.org/en/Introduction_20_804.html.

10.1016/S1499-3872（16）60139-X）